Local News Reaching the Final Stage: Antibody Evolution in COVID-19 ResponseRagon Institute | November 13, 2020For COVID-19, the difference between surviving and not surviving severe disease may be due to…eabramovichNovember 13, 2020 Read More
Local News A Viable Vaccine for Tough TumorsWyss Institute | November 12, 2020Patients with cancer have multiple treatment options available to them today, but each has its…eabramovichNovember 12, 2020 Read More
Local News Study Reveals How Premature Menopause Increases Risk of Cardiovascular DiseaseMassachusetts General Hospital | November 11, 2020Menopause that occurs before a woman is 40 years old accelerates aging and is a…eabramovichNovember 11, 2020 Read More
Local News Researchers Model How Novel Coronavirus Causes Severe Symptoms of COVID-19Beth Israel Deaconess Medical Center | November 11, 2020Since the COVID-19 pandemic began early in 2020, more than 10 million Americans have tested…eabramovichNovember 11, 2020 Read More
Local News Investigators Discover Unique Immune Cells in Patients with Checkpoint Inhibitor-Induced ArthritisHospital for Special Surgery | November 10, 2020Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade…eabramovichNovember 10, 2020 Read More
Local News Single-Cell Study of Ebola Highlights Virus’s Lethal ManeuversBroad Institute | November 9, 2020Ebola virus is one of the world’s deadliest pathogens, and scientists now report new details…eabramovichNovember 9, 2020 Read More
Local News Why Do Some Children Exposed to the Coronavirus Go On to Develop MIS-C?Boston Children’s Hospital | November 6, 2020Most children exposed to the SARS-CoV-2 coronavirus have few or no symptoms. But a small…eabramovichNovember 6, 2020 Read More
Local News Precision Chemo-Immunotherapy for Pancreatic Cancer?Boston Children's Hospital | November 6, 2020Pancreatic cancer is highly lethal and in great need of better treatments. Only about 10 percent of…eabramovichNovember 6, 2020 Read More
Local News 5-Module CAR-T Cells Show Promise for Targeting Pathogenic T Cells and Preventing the Development of Type 1 DiabetesJoslin Diabetes Center | November 5, 2020T cells with a biomimetic-designed chimeric antigen receptor (CAR) can specifically target and eliminate pathogenic…eabramovichNovember 5, 2020 Read More
Local News Study Uncovers Subset of COVID-19 Patients Who Recover Quickly and Sustain AntibodiesBrigham and Women’s Hospital | November 4, 2020One of the pressing questions about COVID-19 remains: How long does immunity last? One key…eabramovichNovember 4, 2020 Read More